Bio-Rad Laboratories (NYSE:BIO) executives said the company finished 2025 within revised guidance for revenue and operating ...

New platform ensures lab orders are policy-aligned, financially ready, and validated before testing begins LabXchange360 flips the revenue model, addressing policy alignment and financial readiness ...

Ltd on Friday reported a 1.9 per cent rise in consolidated net profit at Rs 653.03 crore in the third quarter ended December 31, 2025 on account of impact of new labour codes. The company, which had ...

A new ER is slated for Williamson County's growing northwest city, Fairview.

Alkem Medtech to acquire a 55% stake in Swiss Occlutech for ₹1,074 crore, expanding into advanced cardiovascular devices.

Bio-Rad Laboratories Inc (BIO) reports a 3.9% sales increase in Q4 2025, driven by diagnostics growth, despite supply chain and market headwinds.

Alkem Laboratories reports 1.9% profit rise to ₹653.03 crore and plans to acquire 55% stake in Occlutech for €180.7 million.

Yes, really.

As of Thursday, February 12, QuidelOrtho Corporation’s QDEL share price has dipped by 16.68%, which has investors questioning if this is right time to buy.

Learn why cytotoxicity test failures are common in medical devices and discover systematic approaches to identify root causes ...

NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ -- In the modern medical environment, quality protective ...

The centre aims to assist companies to create the 'next generation' of space technologies and bring research and commerce together ...